Condition
Abnormalities, Radiation-Induced
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00652678TerminatedPrimary
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
NCT01692600CompletedPrimary
Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients
NCT00741754Phase 2CompletedPrimary
Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20
NCT00388713UnknownPrimary
Radiation Induced Atherosclerosis in Breast Cancer Patients
Showing all 4 trials